Sökresultat

Professor Olle Melander at Lund University Diabetes Centre and Skåne University Hospital in Malmö recieves Heart- and Lung Foundation´s large grant of 15 millions swedish crowns. By investigating the genome in tens of thousands has Olle Melander succeeded to identify markers in the blood which increase the risk of suffering from cardiovascular diseases. The next step is to investigate the markers

https://www.ludc.lu.se/article/heart-research-recieves-15-millions-swedish-crowns - 2025-10-03

The fact that diabetes rases the risk of certain types of cancer is already well known, but the reasons have been unclear. Now researchers at Lund University in Sweden have mapped a molecular link that explains the connection between the two widespread diseases. Developing type 2 diabetes is a lengthy process. An early sign that it has begun is high levels of insulin in the blood. As long as the i

https://www.ludc.lu.se/article/molecular-link-between-diabetes-and-cancer-described - 2025-10-03

Despite of more advanced methods than in the routin care it will not be determined which kind of diabetes every fifth new diabetic patient is suffering from. In the ANDIS-project (All New Diabetics In Scania) the concepts will be sorted out. ANDIS also shows that one form of diabetes, LADA, which 15 years ago not even was described is twice as common today as type 1 diabetes. - Diabetes is a more

https://www.ludc.lu.se/article/uncertain-diagnosis-every-fifth-diabetes-patient - 2025-10-03

DPCon2012 Conference Co-chairmen George Andros, MD, and David G. Armstrong, DPM, MD, PhD, are pleased to announce that the Edward James Olmos Award for Advocacy in Amputation Prevention Honoree for 2012 is Jan Apelqvist, MD, PhD. One of the world´s most distinguished experts on the diabetic foot, diabetes-related complications and wound management, a noted researcher, a skilled clinician, a profil

https://www.ludc.lu.se/article/2012-edward-james-olmos-award-advocacy-amputation-prevention - 2025-10-03

For the eight year in a row, Diabetes Research Day is arranged by the Diabetes Programme at Lund University. Apart from several scientific lectures, two awards are handed out. The award that is presented to a PhD student at Lund University Diabetes Centre (LUDC) this year goes to Cecilia Nagorny. She receives this year´s student award in competition with a lot of other PhD students at LUDC. The re

https://www.ludc.lu.se/article/awarded-mapping-hormone-darkness - 2025-10-03

International experts has on behalf of the Swedish Research Council evaluated the first five years activity of Lund University Diabetes Centre (LUDC). The half time evaluation is underlying for the continous grant for the coming five years. All together the rating is "Very well accomplished". 2006 the Research Council and the Research Council for Environment, Agricultural Sciences and Spatial Plan

https://www.ludc.lu.se/article/scientific-grade-world-class-commendation-and-resumed-confidence - 2025-10-03

The Anders Jahre Senior Medical Prize for 2012 of one million Norwegian crowns is awarded to professor Leif Groop, coordinator of Lund University Diabetes Centre. He receives the prize for his ground-breaking research on diabetes, especially for his identification of hereditary factors that predispose to this disease group. Via extensive population-based studies Professor Groop hss shown that diab

https://www.ludc.lu.se/article/2012-jahre-prize-awarded-professor-leif-groop - 2025-10-03

Using a new method, diabetes researchers at Lund University, Sweden, have been able to reveal more of the genetic complexity behind type 2 diabetes. The new research findings have been achieved as a result of access to human insulin-producing cells from deceased donors and through not only studying one gene variant, but many genes and how thay influcence the level of the gene in pancreatic islets

https://www.ludc.lu.se/article/broader-approach-provides-new-insight-diabetes-genes - 2025-10-03

Could a capsule of insulin crystals a day stop the development of type 1 diabetes? There are indications that this could be the case. In the international TrialNet study, which follows relatives of individuals with type 1 diabetes, researchers are investigating whether oral insulin could prevent or delay the disease. Something to offerType 1 diabetes is the autoimmune form of diabetes, in which th

https://www.ludc.lu.se/article/could-oral-insulin-prevent-or-delay-diabetes - 2025-10-03

When a patient is diagnosed with type 2 diabetes, the disease has usually already progressed over several years and damage to areas such as blood vessels and eyes has already taken place. To find a test that indicates who is at risk at an early stage would be valuable, as it would enable preventive treatment to be pTextut in place. Researchers at Lund University have now identified a promising can

https://www.ludc.lu.se/article/protein-reveals-diabetes-risk-many-years-advance - 2025-10-03

Researchers at Lund University, Sweden, are studying whether it is possible to prevent obesity, diabetes and cardiovascular disease by reducing levels of the hormone vasopressin in the blood. 
- If you dilute the blood by drinking water, the body releases less of the hormone vasopressin, which can potentially lead to diabetes, says Sofia Enhörning, a doctor who has recently completed her PhD at Lu

https://www.ludc.lu.se/article/could-normal-water-prevent-diabetes-obesity-and-cardiovascular-disease - 2025-10-03

Anders Rosengren and Ola Hansson from Lund University Diabetes Centre has been granted with 50.000 euro each from the Bo & Kerstin Hjelt Foundation for type 2 diabetes research. The 2013 grant will finance Anders Rosengrens project entitled "New anti-diabetic treatments through gene network analysis" and the project led by Ola Hansson is entitled "Mechanisms whereby genetic variation in the TCF7L2

https://www.ludc.lu.se/article/new-grants-hjelt-foundation - 2025-10-03

Type 2 diabetes has strong hereditary tendencies and the genes we are born with cannot be changed. However, new research from Lund University in Sweden shows that we can modify the function of the genes through the epigenetic changes that take place in the course of life. Epigenetic changes are usually described as a link between heredity and environment and come about as a result of factors such

https://www.ludc.lu.se/article/new-clues-hunt-heredity-type-2-diabetes - 2025-10-03

The majority of patients with type 2 diabetes who undergo a gastric bypass operation recover from the disease within a few days of the operation, long before their body weight falls. No one knows how this happens, but researchers at Lund University Diabetes Centre in Sweden have now come up with a partial answer. In the long term, we aim to identify new treatment strategies that could imitate the

https://www.ludc.lu.se/article/early-partial-answer-why-obesity-operations-cause-remission-diabetes - 2025-10-03

In recent years, researchers have discovered around 70 genetic risk variants for diabetes, but still TCF7L2, known as the diabetes gene, is the gene that carries with it the largest risk of developing type 2 diabetes. Using a new method called exon skipping, Ola Hansson at Lund University Diabetes Centre (LUDC) wants to learn more about TCF7L2 by studying new ways of delaying the onset of type 2 d

https://www.ludc.lu.se/article/method-which-repairs-damaged-genes - 2025-10-03

Using a simple blood sample, it is now possible to identify people at risk of developing type 2 diabetes in the future. In a new project, Anders Rosengren, researcher at Lund University Diabetes Centre and physician at Skåne University Hospital in Malmö, has identified a new risk protein for type 2 diabetes. Anders Rosengren is one of four researchers who was awarded 50 000 euro from the Hjelt Fou

https://www.ludc.lu.se/article/inflammation-inhibitorial-medicines-will-prevent-type-2 - 2025-10-03

Researchers at Lund University in Sweden have discovered how to stop the destructive process that leads to cardiovascular disease in diabetic laboratory animals. It is well known that high blood sugar levels significantly raise the risk of cardiovascular disease. It is unclear, however, why this happens. An important part of the explanation may be NFAT, a protein activated when blood sugar is rais

https://www.ludc.lu.se/article/protein-block-stops-vascular-damage-diabetes - 2025-10-03

Researchers at Lund University in Sweden have developed a new mouse model that answers the question of what actually happens in the body when type 2 diabetes develops and how the body responds to drug treatment. Long-term studies of the middle-aged mouse model will be better than previous studies at confirming how drugs for type 2 diabetes function in humans. “The animal models for type 2 diabetes

https://www.ludc.lu.se/article/new-mouse-model-confirms-how-type-2-diabetes-develops - 2025-10-03

Exercise, even in small doses, changes the expression of our innate DNA. New research from Lund University in Sweden has described for the first time what happens on an epigenetic level in fat cells when we undertake physical activity. “Our study shows the positive effects of exercise, because the epigenetic pattern of genes that affect fat storage in the body changes”, says Charlotte Ling, Associ

https://www.ludc.lu.se/article/epigenetic-changes-fat-cells-following-exercise - 2025-10-03

Is it time for a new nutritional supplement during pregnancy to prevent type 1 diabetes in the unborn child? Two new scientific studies, one from Lund University in Sweden, and another from Finland, suggest so. The research groups have analysed blood samples from umbilical cords and compared the level of a group of fats known as phospholipids. The results of the studies show that low levels of pho

https://www.ludc.lu.se/article/could-supplements-during-pregnancy-reduce-child-diabetes-risk - 2025-10-03